5-methyl-2-(1H-pyrazol-1-yl)benzoic acid | 1214622-46-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-methyl-2-(1H-pyrazol-1-yl)benzoic acid
• 英文别名: 5-methyl-2-pyrazol-1-ylbenzoic acid
• CAS: 1214622-46-4
• 化学式: C₁₁H₁₀N₂O₂
• 分子量: 202.213
• InChiKey: FILIVWMASJBSKK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  55.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-methyl-2-(1H-pyrazol-1-yl)benzoic acid 、 碘甲烷 在 caesium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 0.5h， 以71%的产率得到2-(1H-pyrazol-1-yl)-1,3-benzendicarboxylic acid 1,3-dimethyl ester
  参考文献：
  名称：

  Ruthenium-Catalyzed C–H Silylation of 1-Arylpyrazole Derivatives and Fluoride-Mediated Carboxylation: Use of Two Nitrogen Atoms of the Pyrazole Group

  摘要：

  Carboxylation of 1-arylpyrazole derivatives was developed using a ruthenium-catalyzed ortho silylation in conjunction with fluoride-mediated carboxylation with carbon dioxide. The two nitrogen atoms of pyrazole play crucial roles in promoting ortho silylation via the formation of a five-membered ruthenacycle and in accelerating aryl anion formation by lowering the electron density of the aromatic ring.

  DOI：

  10.1055/s-0033-1341230
• 作为产物：
  描述：

  1-(对甲苯基)-1H-吡唑 在 RuH₂(CO)(PPh₃)₃ 、 norbornene 、 cesium fluoride 作用下， 以 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 100.0 ℃ 、101.33 kPa 条件下， 反应 100.0h， 生成 5-methyl-2-(1H-pyrazol-1-yl)benzoic acid
  参考文献：
  名称：

  Ruthenium-Catalyzed C–H Silylation of 1-Arylpyrazole Derivatives and Fluoride-Mediated Carboxylation: Use of Two Nitrogen Atoms of the Pyrazole Group

  摘要：

  Carboxylation of 1-arylpyrazole derivatives was developed using a ruthenium-catalyzed ortho silylation in conjunction with fluoride-mediated carboxylation with carbon dioxide. The two nitrogen atoms of pyrazole play crucial roles in promoting ortho silylation via the formation of a five-membered ruthenacycle and in accelerating aryl anion formation by lowering the electron density of the aromatic ring.

  DOI：

  10.1055/s-0033-1341230

文献信息

• [EN] NOVEL N-[(PYRIMIDINYLOXY)PROPANYL]BENZAMIDES<br/>[FR] NOUVEAUX N-[(HÉTÉROARYLOXY)PROPANYL]HÉTÉROARYL CARBOXAMIDES
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2017178338A1

  公开（公告）日：2017-10-19

  This invention relates to compounds of formula (I), a process for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions having an association with the orexin sub-type 1 receptor. Ar, R1, R2, R3, R4, R5 have meanings given in the description.

  这项发明涉及到式(I)的化合物，其制备方法，含有它们的药物组合物以及它们在治疗与促觉醒素亚型1受体相关的疾病中的应用。Ar，R1，R2，R3，R4，R5的含义如描述中所示。
• [EN] NOVEL N-[(PYRAZINYLOXY)PROPANYL]BENZAMIDES<br/>[FR] NOUVEAUX N-[(PYRAZINYLOXY)PROPANYL]BENZAMIDES
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2017178339A1

  公开（公告）日：2017-10-19

  This invention relates to compounds of formula (I) a process for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions having an association with the orexin sub-type 1 receptor. Ar, R1, R2 and R3 have meanings given in the description.

  这项发明涉及式(I)的化合物，其制备方法，含有它们的药物组合物以及它们在治疗与促觉肽亚型1受体相关的疾病中的应用。Ar、R1、R2和R3的含义如描述中所示。
• Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists
  作者：Jodi T. Williams、John Gatfield、Catherine Roch、Alexander Treiber、Francois Jenck、Martin H. Bolli、Christine Brotschi、Thierry Sifferlen、Bibia Heidmann、Christoph Boss

  DOI：10.1039/c5md00074b

  日期：——

  1-acyl-2-benzylpyrrolidines were discovered as potent and competitive dual orexin receptor antagonists. Metabolic stability was improved to afford oral exposure, and aqueous solubility was increased by twentyfold, providing compounds suitable for preclinical evaluation. Compound 27 showed insurmountable antagonism at both orexin 1 and orexin 2 receptor subtypes and displayed a comparable sleep-promoting

  从在大鼠和人肝微粒体中具有高固有清除率和低水溶性的噻吩并哌啶前导化合物开始，发现了一系列新型的1-酰基-2-苄基吡咯烷酮，它们是有效且具有竞争力的双重orexin受体拮抗剂。改善了代谢稳定性以提供口服暴露，并且水溶性增加了二十倍，从而提供了适合临床前评估的化合物。化合物27对orexin 1和orexin 2受体亚型均显示出不可克服的拮抗作用，并且在大鼠中具有与Almorexant和suvorexant相当的促睡眠作用。
• [EN] NOVEL N-[(PYRIDYLOXY)PROPANYL]BENZAMIDES<br/>[FR] NOUVEAUX N-[(PYRIDYLOXY)PROPANYL]BENZAMIDES
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2017178340A1

  公开（公告）日：2017-10-19

  This invention relates to compounds of formula (I), a process for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions having an association with the orexin sub-type 1 receptor. Ar, R1, R2, R3, R4, R5, R6 and R7 have meanings given in the description.

  这项发明涉及式(I)的化合物，其制备方法，含有它们的药物组合物以及它们在治疗与促进素亚型1受体相关的疾病中的应用。Ar，R1，R2，R3，R4，R5，R6和R7的含义如描述中所示。
• Regiodivergent C−H and Decarboxylative C−C Alkylation by Ruthenium Catalysis: <i>ortho</i> versus <i>meta</i> Position‐Selectivity
  作者：Korkit Korvorapun、Marc Moselage、Julia Struwe、Torben Rogge、Antonis M. Messinis、Lutz Ackermann

  DOI：10.1002/anie.202007144

  日期：2020.10.12

  Ruthenium(II)biscarboxylate complexes enabled the selective alkylation of C−H and C−C bonds at the ortho‐ or meta‐position. ortho‐C−H Alkylations were achieved with 4‐, 5‐ as well as 6‐membered halocycloalkanes. Furthermore, the judicious choice of the directing group allowed for a full control of ortho‐/meta‐selectivities. Detailed mechanistic studies by experiment and computation were performed and

  双羧酸钌(II)配合物能够在邻位或间位选择性烷基化CH和CC键。邻位-C-H烷基化是用4-、5-以及6-元卤代环烷烃实现的。此外，指导小组的明智选择可以完全控制邻位/间位选择性。通过实验和计算进行了详细的机理研究，为邻位烷基化的氧化加成/还原消除过程提供了强有力的支持，而均裂CX裂解可用于间位选择性转化。